Dr. Christine Savage, M.D.
What this data tells you about Dr. Savage
Dr. Christine Savage is a rheumatology in Loxahatchee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Savage performed 126,485 Medicare services across 1,397 unique beneficiaries.
Between the years covered by Open Payments, Dr. Savage received a total of $34,985 from 53 pharmaceutical and/or device companies across 1340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Savage is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 60,000 | $4 | $11 |
| Romosozumab injection (Evenity) for osteoporosis | 25,620 | $8 | $21 |
| Tocilizumab injection (Actemra) | 22,080 | $5 | $11 |
| Golimumab infusion (Simponi Aria) | 8,101 | $7 | $20 |
| Denosumab injection (Prolia/Xgeva) | 7,920 | $18 | $44 |
| Office visit, established patient (30-39 min) | 845 | $96 | $270 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 579 | $60 | $189 |
| Administration of chemotherapy into vein, 1 hour or less | 278 | $104 | $345 |
| Office visit, established patient, complex (40-54 min) | 127 | $131 | $364 |
| Injection of additional new drug or substance into vein | 126 | $13 | $85 |
| Administration of chemotherapy into vein, each additional hour | 117 | $23 | $110 |
| X-ray of hand, minimum of 3 views | 77 | $28 | $77 |
| Joint injection, major joint | 75 | $45 | $175 |
| New patient office visit (45-59 min) | 75 | $118 | $415 |
| Office visit, established patient (20-29 min) | 74 | $65 | $184 |
| Foot X-ray, 3+ views | 73 | $28 | $73 |
| X-ray of wrist, minimum of 3 views | 60 | $34 | $96 |
| Knee X-ray, 3 views | 46 | $34 | $90 |
| Injection, methylprednisolone acetate, 40 mg | 42 | $6 | $30 |
| X-ray of ankle, minimum of 3 views | 36 | $31 | $75 |
| X-ray of lower and sacral spine, minimum of 4 views | 27 | $38 | $123 |
| Shoulder X-ray, 2+ views | 26 | $29 | $73 |
| Injection, methylprednisolone acetate, 20 mg | 21 | $4 | $20 |
| Betamethasone steroid injection | 18 | $5 | $12 |
| X-ray of upper spine, 4-5 views | 17 | $41 | $125 |
| Aspiration and/or injection of fluid from small joint | 13 | $38 | $135 |
| New patient office visit, complex (60-74 min) | 12 | $179 | $521 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Savage is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), and high industry engagement (low-engagement, top 14%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Savage experienced with certolizumab injection (cimzia)?
Does Dr. Savage receive payments from pharmaceutical companies?
How do Dr. Savage's costs compare to other rheumatologys in Loxahatchee?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology